Pharming Group N.V. (PHAR)

NASDAQ: PHAR · Real-Time Price · USD

11.90

+0.70 (6.25%)

At close: Oct 26, 2026, 4:00 PM EDT

11.90

0.00 (0.00%)

Pre-market: Oct 27, 2026, 4:00 AM EDT

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	834	1,147	650	763	756	572
Market Cap Growth	-7.69%	76.58%	-14.84%	0.93%	32.18%	-42.41%
Enterprise Value	790	1,112	608	728	702	554
Last Close Price	11.90	17.67	10.06	11.43	11.03	8.94

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	96.25	402.37	-	-	55.27	35.75
PS Ratio	2.28	3.05	2.19	3.11	3.68	2.88
PB Ratio	3.08	4.14	2.94	3.49	3.69	2.96
P/TBV Ratio	5.86	8.10	4.06	5.17	5.82	5.23
P/FCF Ratio	24.28	21.26	-	-	35.85	21.10
P/OCF Ratio	23.82	20.97	-	-	33.66	15.11

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.16	2.96	2.05	2.97	3.41	2.78
EV/EBITDA Ratio	24.03	28.07	188.69	-	40.97	18.22
EV/EBIT Ratio	31.17	33.94	-	-	67.70	23.07
EV/FCF Ratio	22.99	20.61	-	-	33.29	20.43

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.42	0.42	0.51	0.78	0.82	0.84
Debt / EBITDA Ratio	3.12	2.69	17.02	-	8.46	4.88
Debt / FCF Ratio	3.30	2.15	-	-	7.91	5.97
Net Debt / Equity Ratio	-0.17	-0.23	-0.25	-0.19	-0.20	-0.16
Net Debt / EBITDA Ratio	-1.37	-1.60	-17.24	2.74	-2.37	-0.99
Net Debt / FCF Ratio	-1.31	-1.17	21.50	2.24	-1.93	-1.11
Asset Turnover	0.80	0.84	0.69	0.55	0.50	0.49
Inventory Turnover	0.77	0.75	0.63	0.51	0.50	0.87
Quick Ratio	2.31	1.97	2.96	3.28	3.90	4.69
Current Ratio	3.01	2.59	3.77	4.06	4.65	5.33
Return on Equity (ROE)	3.65%	1.02%	-5.38%	-4.98%	6.88%	8.50%
Return on Assets (ROA)	3.47%	4.55%	-0.52%	-3.06%	1.57%	3.68%
Return on Invested Capital (ROIC)	6.76%	3.41%	-2.10%	-12.76%	5.79%	10.98%
Return on Capital Employed (ROCE)	6.80%	8.50%	-1.10%	-5.70%	2.80%	6.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.04%	0.25%	-1.82%	-1.38%	1.81%	2.80%
FCF Yield	4.12%	4.70%	-0.40%	-2.46%	2.79%	4.74%
Buyback Yield / Dilution	-12.83%	-11.25%	-2.18%	7.09%	-0.85%	-2.70%

SEC Filings: 10-K · 10-Q